Menu Menu

Caring for people with COVID-19

Supporting Australia’s healthcare professionals with continually updated, evidence-based clinical guidelines

02/12/22: Communique from the National Steering Committee

Living
guidelines

Evidence-based clinical COVID-19 guidelines updated with the latest research

We have developed recommendations that cover:

View all evidence-based recommendations here:

We will revise and add recommendations each week as our evidence teams and expert panels identify priority clinical questions and synthesise new research.

Clinical
flowcharts

Flowcharts incorporating living guideline recommendations and guidance issued or endorsed by Taskforce members

Risk classification

Decision tools

Drug treatments

Pathways to care

Management of COVID-19 and care after COVID-19

Management of special populations

CPR during the pandemic

Changes to flowcharts reflect:

  • Updated molnupiravir recommendation
  • Recent recommendations from the Infection Control Expert Group (ICEG)
  • Simplification of messaging regarding differences to the previously accepted standard practice.
  • The different circumstances since the original flowcharts were created, when population was not vaccinated, and appropriate PPE was sometimes scarce

Topics
under review

Continuously reviewing new evidence to update recommendations and address new priority questions

We are currently reviewing evidence to develop recommendations and flowcharts to guide practice in areas including:

  • Care of people after COVID-19
  • Infliximab
  • Abatacept
  • Tixagevimab plus cilgavimab (Evusheld; pregnancy)
  • Regdanvimab (Regkirona; pregnancy)
  • Vilobelimab
  • Inhaled corticosteroids
  • Corticosteroids (systemic)

Expert Panels

Do you have a clinical question?

Your views help us to identify and prioritise questions to include in the living guideline.

envelope iconSubscribe here to receive regular updates from the Taskforce

PERSONAL DETAILS

Please enter your email, so we can follow up with you.

SUGGESTIONS

Suggest a new topic or clinical question. Please note that our living guideline aims to

“Provide specific, patient-focused recommendations for the clinical care of people with suspected or confirmed COVID-19, where care for this patient group differs from usual care provided to patients with similar clinical conditions (pneumonia, severe acute respiratory distress, etc.)”.


*The following topics for COVID-19 are currently included:

• Definition of disease severity
• Monitoring and markers of clinical deterioration
• Drug treatments (e.g. antimalarials)
• Chemoprophylaxis
• Respiratory support in adults
• Respiratory support in neonates, children and adolescents
• Venous thromboembolism (VTE) prophylaxis
• Therapies for existing indications in patients with COVID-19
• Care of people after COVID-19
• Timing of surgery following COVID-19 infection
• Pregnancy and perinatal care
• Child and adolescent care

*The following topics for MPX are currently included:

• Disease severity and risk of severe disease
• Drug treatments
• Supportive care
• Pregnancy and perinatal care
• Paediatric and adolescent care

AGREEMENTS

Please enter your email to receive our regular updates.

COVID-19
Research

Find COVID-19 studies around the world

Cochrane’s COVID-19 Study Register is a freely-available, continually-updated, annotated reference collection of human studies on COVID-19, including interventional, observational, diagnostic, prognostic, epidemiological, and economic designs.

Find COVID-19 studies in Australia

The ANZCTR is an online registry of clinical trials being undertaken in Australia, New Zealand and elsewhere. A list of coronavirus/COVID-19 studies currently recruiting in Australia is available here.

Core Outcomes for COVID-19 Research

The COVID-19-COS project is an international initiative bringing together patients, the public and health professionals to identify, prioritise and agree on the most important outcomes for research in COVID-19.

Partners
and funders